How a Pomegranate Compound May Protect Your Heart—New Research Explains
Published April 27, 2026
Heart disease remains the leading cause of death worldwide, but emerging research suggests a surprising ally in the fight against it: pomegranates. Specifically, a compound called urolithin A, produced when gut bacteria metabolize pomegranate polyphenols, may help protect arteries from plaque buildup and inflammation—key drivers of heart attacks and strokes. A new study from Cardiff University sheds light on how this natural molecule could offer a novel approach to cardiovascular health, targeting the root causes of atherosclerosis rather than just lowering cholesterol.
Key Takeaways
- Urolithin A, a metabolite of pomegranate polyphenols, may reduce arterial plaque buildup by lowering oxidative stress and inflammation.
- Gut bacteria convert pomegranate compounds (like punicalagin) into urolithins, which are more bioavailable and active in the body.
- Preclinical studies show urolithin A limits immune cell infiltration into vessel walls and decreases cholesterol accumulation in macrophages.
- While promising, human trials are needed to confirm these effects in real-world settings.
The Science Behind Pomegranate’s Heart-Protective Effects
From Fruit to Metabolite: How Urolithin A Forms
Pomegranates are rich in punicalagins, a type of polyphenol long associated with cardiovascular benefits. However, the body absorbs very little of these compounds directly. Instead, gut bacteria break them down into smaller, more active molecules called urolithins. Among these, urolithin A has shown the most promise in preclinical research for its ability to:
- Reduce oxidative stress in arterial cells.
- Lower inflammation by limiting immune cell migration into vessel walls.
- Decrease cholesterol buildup in macrophages, a type of immune cell that contributes to plaque formation.
“The real biological effects come from what gut bacteria make from pomegranate compounds, rather than from the compounds in the fruit itself,” explains Professor Dipak Ramji, senior author of the study and Professor of Cardiovascular Science at Cardiff University. This insight shifts the focus from the fruit to its microbial metabolites, which may be the true drivers of its heart-protective properties.
How Urolithin A Targets Atherosclerosis
Atherosclerosis, the hardening and narrowing of arteries due to plaque buildup, is the primary cause of most heart attacks and strokes. Traditional approaches to managing this condition often focus on lowering cholesterol or blood pressure. However, urolithin A appears to address the underlying biology of plaque formation in several ways:
- Reducing Oxidative Stress: Oxidative stress damages arterial walls, making them more susceptible to plaque buildup. Urolithin A’s antioxidant properties help neutralize free radicals, protecting vessel integrity.
- Limiting Inflammation: Chronic inflammation in arteries attracts immune cells, which can worsen plaque growth. Urolithin A reduces the movement of these cells into vessel walls, slowing the progression of atherosclerosis.
- Preventing Cholesterol Accumulation: Macrophages, a type of immune cell, can develop into overwhelmed with cholesterol, turning into foam cells that contribute to plaque. Urolithin A decreases cholesterol buildup in these cells, reducing plaque formation.
The study, published in the journal Antioxidants, tested punicalagin, its intermediate form ellagic acid, and several urolithins in human immune and blood vessel cells grown in the lab. The results highlighted urolithin A as the most effective metabolite for cardiovascular protection.
What This Means for Human Health
Preclinical Success, But Human Trials Needed
While the findings are promising, it’s important to note that the research is still in its early stages. The study was conducted in preclinical models, meaning the effects of urolithin A have not yet been confirmed in human trials. However, the results align with previous research on pomegranate’s cardiovascular benefits, including:
- Reductions in blood pressure and oxidative stress in animal studies.
- Improvements in endothelial function (the health of blood vessel linings) in some human trials.
- Potential anti-atherogenic effects, though human data remains limited.
For now, the research underscores the importance of gut health in cardiovascular protection. Not everyone’s gut bacteria can efficiently convert pomegranate polyphenols into urolithins, which may explain why some individuals experience more pronounced benefits from pomegranate consumption than others.
Should You Eat More Pomegranates?
Pomegranates are a nutritious fruit, packed with antioxidants, fiber, and vitamins. While the new research highlights their potential cardiovascular benefits, it’s too early to recommend them as a standalone treatment for heart disease. However, incorporating pomegranates into a balanced diet—alongside other heart-healthy foods like leafy greens, nuts, and fatty fish—may offer protective benefits.
For those interested in maximizing the potential benefits, consider:
- Whole fruit or juice: Both contain punicalagins, though whole fruit provides additional fiber.
- Supplements: Some supplements contain concentrated pomegranate extract or urolithin A, but their efficacy and safety require further study.
- Gut health: A diverse microbiome may enhance the body’s ability to produce urolithins. Probiotic and prebiotic foods (like yogurt, kefir, and whole grains) can support gut health.
Frequently Asked Questions
1. What is urolithin A, and how is it related to pomegranates?
Urolithin A is a compound produced when gut bacteria metabolize polyphenols found in pomegranates, such as punicalagin. Unlike the polyphenols themselves, urolithin A is more easily absorbed into the bloodstream and has been shown in preclinical studies to protect against atherosclerosis by reducing oxidative stress and inflammation.
2. Can eating pomegranates prevent heart disease?
While pomegranates contain heart-healthy compounds, there is currently no evidence that they can prevent heart disease on their own. However, they may contribute to overall cardiovascular health as part of a balanced diet. The new research suggests that the benefits may be linked to gut bacteria’s ability to convert pomegranate polyphenols into urolithins like urolithin A.
3. Are pomegranate supplements as effective as the fruit?
Supplements may provide concentrated doses of pomegranate compounds, but their effectiveness and safety are not yet well-established. Whole pomegranates offer additional nutrients, such as fiber, that supplements lack. If considering supplements, consult a healthcare provider to discuss potential benefits and risks.
4. Who might benefit most from pomegranate consumption?
Individuals with a diverse gut microbiome may benefit more from pomegranate consumption, as their gut bacteria are more likely to efficiently convert polyphenols into urolithins. However, more research is needed to determine who might experience the most significant cardiovascular benefits.
5. Are there any risks associated with pomegranate consumption?
Pomegranates are generally safe for most people, but they can interact with certain medications, such as blood thinners and blood pressure drugs. If you have a medical condition or take prescription medications, consult your healthcare provider before making significant changes to your diet.
The Future of Heart Health Research
The discovery of urolithin A’s potential cardiovascular benefits highlights the growing recognition of gut health’s role in overall well-being. As researchers continue to explore the connection between diet, gut bacteria, and heart disease, we may witness new dietary recommendations or even targeted therapies based on these findings.
For now, the research serves as a reminder that nature often holds the keys to complex health challenges. While pomegranates alone won’t solve heart disease, they may be one piece of a larger puzzle—one that includes a balanced diet, regular exercise, and proactive healthcare.
As Professor Ramji notes, “This is just the beginning. Understanding how gut bacteria interact with the foods we eat could open new avenues for preventing and treating cardiovascular disease.”